Zobrazeno 1 - 10
of 7 137
pro vyhledávání: '"Sorek R"'
Autor:
Hör J; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.; Helmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), Würzburg, Germany., Wolf SG; Department of Chemical Research Support, Weizmann Institute of Science, Rehovot, Israel., Sorek R; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel. rotem.sorek@weizmann.ac.il.
Publikováno v:
Nature [Nature] 2024 Jul; Vol. 631 (8022), pp. 850-856. Date of Electronic Publication: 2024 Jul 17.
Autor:
Yirmiya E; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel., Leavitt A; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel., Lu A; Department of Microbiology, Harvard Medical School, Boston, MA, USA.; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA., Ragucci AE; Department of Microbiology, Harvard Medical School, Boston, MA, USA.; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA., Avraham C; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel., Osterman I; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel., Garb J; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel., Antine SP; Department of Microbiology, Harvard Medical School, Boston, MA, USA.; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA., Mooney SE; Department of Microbiology, Harvard Medical School, Boston, MA, USA.; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA., Hobbs SJ; Department of Microbiology, Harvard Medical School, Boston, MA, USA.; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA., Kranzusch PJ; Department of Microbiology, Harvard Medical School, Boston, MA, USA.; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.; Parker Institute for Cancer Immunotherapy at Dana-Farber Cancer Institute, Boston, MA, USA., Amitai G; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel. gil.amitai@weizmann.ac.il., Sorek R; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel. rotem.sorek@weizmann.ac.il.
Publikováno v:
Nature [Nature] 2024 Jan; Vol. 625 (7994), pp. 352-359. Date of Electronic Publication: 2023 Nov 22.
Autor:
Béchon N; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel., Tal N; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel., Stokar-Avihail A; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel., Savidor A; de Botton Institute for Protein Profiling, The Nancy and Stephen Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, Rehovot, Israel., Kupervaser M; de Botton Institute for Protein Profiling, The Nancy and Stephen Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, Rehovot, Israel., Melamed S; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel., Amitai G; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel., Sorek R; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel. rotem.sorek@weizmann.ac.il.
Publikováno v:
Nature communications [Nat Commun] 2024 Nov 14; Vol. 15 (1), pp. 9860. Date of Electronic Publication: 2024 Nov 14.
Autor:
Osterman I; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel., Sorek R; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Publikováno v:
Science (New York, N.Y.) [Science] 2024 Oct 04; Vol. 386 (6717), pp. 25-26. Date of Electronic Publication: 2024 Aug 29.
Autor:
Osterman I; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel. ilya.osterman@weizmann.ac.il., Samra H; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel., Rousset F; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel., Loseva E; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel., Itkin M; Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel., Malitsky S; Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel., Yirmiya E; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel., Millman A; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel., Sorek R; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel. rotem.sorek@weizmann.ac.il.
Publikováno v:
Nature [Nature] 2024 Oct; Vol. 634 (8036), pp. 1160-1167. Date of Electronic Publication: 2024 Sep 25.
Autor:
Osterman I; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel., Sorek R; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel. rotem.sorek@weizmann.ac.il.
Publikováno v:
Nature biotechnology [Nat Biotechnol] 2024 Sep 09. Date of Electronic Publication: 2024 Sep 09.
Autor:
Garb J; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel., Amitai G; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel., Lu A; Department of Microbiology, Harvard Medical School, Boston, MA, United States of America.; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, United States of America., Ofir G; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel., Brandis A; Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel., Mehlman T; Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel., Kranzusch PJ; Department of Microbiology, Harvard Medical School, Boston, MA, United States of America.; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, United States of America.; Parker Institute for Cancer Immunotherapy at Dana-Farber Cancer Institute, Boston, MA, United States of America., Sorek R; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Publikováno v:
PloS one [PLoS One] 2024 Apr 18; Vol. 19 (4), pp. e0302251. Date of Electronic Publication: 2024 Apr 18 (Print Publication: 2024).
Autor:
Tamulaitiene G; Institute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius, Lithuania. giedre.tamulaitiene@bti.vu.lt., Sabonis D; Institute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius, Lithuania., Sasnauskas G; Institute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius, Lithuania., Ruksenaite A; Institute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius, Lithuania., Silanskas A; Institute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius, Lithuania., Avraham C; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel., Ofir G; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.; Department of Molecular Biology, Max Planck Institute for Biology Tübingen, Tübingen, Germany., Sorek R; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel., Zaremba M; Institute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius, Lithuania. mindaugas.zaremba@bti.vu.lt., Siksnys V; Institute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius, Lithuania. siksnys@ibt.lt.
Publikováno v:
Nature [Nature] 2024 Mar; Vol. 627 (8003), pp. 431-436. Date of Electronic Publication: 2024 Feb 21.
Autor:
Wein T; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel., Sorek R; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel. rotem.sorek@weizmann.ac.il.
Publikováno v:
Nature reviews. Immunology [Nat Rev Immunol] 2022 Oct; Vol. 22 (10), pp. 629-638. Date of Electronic Publication: 2022 Apr 08.
Autor:
Antine SP; Department of Microbiology, Harvard Medical School, Boston, MA, USA.; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA., Johnson AG; Department of Microbiology, Harvard Medical School, Boston, MA, USA.; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA., Mooney SE; Department of Microbiology, Harvard Medical School, Boston, MA, USA.; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA., Leavitt A; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel., Mayer ML; Harvard Center for Cryo-Electron Microscopy, Harvard Medical School, Boston, MA, USA., Yirmiya E; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel., Amitai G; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel., Sorek R; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel., Kranzusch PJ; Department of Microbiology, Harvard Medical School, Boston, MA, USA. philip_kranzusch@dfci.harvard.edu.; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA. philip_kranzusch@dfci.harvard.edu.; Parker Institute for Cancer Immunotherapy at Dana-Farber Cancer Institute, Boston, MA, USA. philip_kranzusch@dfci.harvard.edu.
Publikováno v:
Nature [Nature] 2024 Jan; Vol. 625 (7994), pp. 360-365. Date of Electronic Publication: 2023 Nov 22.